Changjun Lv

机构：Binzhou Medical University, Shandong University of Aeronautics, Shandong Institute of Business and Technology · ORCID：0000-0002-7048-5264

发表论文 151 篇 · 总被引 5304 次 · h-index 43

代表论文

• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
• YTHDC1 phase separation drives the nuclear export of m6A-modified lncNONMMUT062668.2 through the transport complex SRSF3–ALYREF–XPO5 to aggravate pulmonary fibrosis (2025 · Cell Death and Disease · 被引 17)
• STAT3 Facilitates Super Enhancer Formation to Promote Fibroblast‐To‐Myofibroblast Differentiation by the Analysis of ATAC ‐Seq, RNA ‐Seq and ChIP ‐Seq (2025 · Journal of Cellular and Molecular Medicine · 被引 10)
• Integrated multi-omics analysis reveals PTM networks as key regulators of colorectal cancer progression and immune evasion (2025 · Discover Oncology · 被引 8)
• Integrating CRISPR-Cas12a with Aptamer as a Logic Gate Biosensing Platform for the Detection of CD33 and CD123 (2025 · ACS Omega · 被引 7)
• circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway (2025 · Cellular and Molecular Life Sciences · 被引 7)